annual cash & cash equivalents:
$9.99B+$3.91B(+64.19%)Summary
- As of today (August 22, 2025), GILD annual cash & cash equivalents is $9.99 billion, with the most recent change of +$3.91 billion (+64.19%) on December 31, 2024.
- During the last 3 years, GILD annual cash & cash equivalents has risen by +$4.65 billion (+87.17%).
- GILD annual cash & cash equivalents is now -44.31% below its all-time high of $17.94 billion, reached on December 31, 2018.
Performance
GILD Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$6.52B-$2.61B(-28.55%)Summary
- As of today (August 22, 2025), GILD quarterly cash & cash equivalents is $6.52 billion, with the most recent change of -$2.61 billion (-28.55%) on June 30, 2025.
- Over the past year, GILD quarterly cash & cash equivalents has increased by +$2.33 billion (+55.38%).
- GILD quarterly cash & cash equivalents is now -78.93% below its all-time high of $30.95 billion, reached on December 31, 2018.
Performance
GILD quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GILD Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.2% | +55.4% |
| 3 y3 years | +87.2% | +15.2% |
| 5 y5 years | -14.1% | -66.3% |
GILD Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.2% | -43.6% | +55.4% |
| 5 y | 5-year | -14.1% | +87.2% | -73.9% | +55.4% |
| alltime | all time | -44.3% | >+9999.0% | -78.9% | >+9999.0% |
GILD Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.52B(-28.6%) |
| Mar 2025 | - | $9.13B(-21.1%) |
| Dec 2024 | $9.99B(+64.2%) | $11.57B(+72.7%) |
| Sep 2024 | - | $6.70B(+59.5%) |
| Jun 2024 | - | $4.20B(-30.7%) |
| Mar 2024 | - | $6.06B(-27.4%) |
| Dec 2023 | $6.08B(+12.4%) | $8.35B(+4.7%) |
| Sep 2023 | - | $7.97B(+12.3%) |
| Jun 2023 | - | $7.10B(+13.3%) |
| Mar 2023 | - | $6.27B(-8.6%) |
| Dec 2022 | $5.41B(+1.4%) | $6.86B(+9.9%) |
| Sep 2022 | - | $6.24B(+10.2%) |
| Jun 2022 | - | $5.66B(+6.3%) |
| Mar 2022 | - | $5.33B(-28.1%) |
| Dec 2021 | $5.34B(-11.0%) | $7.41B(+12.0%) |
| Sep 2021 | - | $6.61B(-3.4%) |
| Jun 2021 | - | $6.84B(+5.9%) |
| Mar 2021 | - | $6.46B(-21.8%) |
| Dec 2020 | $6.00B(-48.4%) | $8.26B(-66.9%) |
| Sep 2020 | - | $24.96B(+28.9%) |
| Jun 2020 | - | $19.36B(-7.9%) |
| Mar 2020 | - | $21.02B(-14.8%) |
| Dec 2019 | $11.63B(-35.2%) | $24.67B(+6.6%) |
| Sep 2019 | - | $23.15B(-18.4%) |
| Jun 2019 | - | $28.37B(-2.2%) |
| Mar 2019 | - | $29.01B(-6.3%) |
| Dec 2018 | $17.94B(+136.4%) | $30.95B(+5.7%) |
| Sep 2018 | - | $29.30B(+10.2%) |
| Jun 2018 | - | $26.58B(+7.7%) |
| Mar 2018 | - | $24.68B(-5.6%) |
| Dec 2017 | $7.59B(-7.8%) | $26.14B(-10.1%) |
| Sep 2017 | - | $29.07B(+34.5%) |
| Jun 2017 | - | $21.61B(+46.9%) |
| Mar 2017 | - | $14.71B(+23.6%) |
| Dec 2016 | $8.23B(-36.0%) | $11.89B(-3.0%) |
| Sep 2016 | - | $12.27B(+40.2%) |
| Jun 2016 | - | $8.75B(+5.2%) |
| Mar 2016 | - | $8.32B(-43.0%) |
| Dec 2015 | $12.85B(+28.2%) | $14.61B(-7.0%) |
| Sep 2015 | - | $15.71B(+82.5%) |
| Jun 2015 | - | $8.61B(-23.8%) |
| Mar 2015 | - | $11.29B(+11.5%) |
| Dec 2014 | $10.03B(+374.5%) | $10.13B(+60.3%) |
| Sep 2014 | - | $6.32B(-28.2%) |
| Jun 2014 | - | $8.80B(+36.0%) |
| Mar 2014 | - | $6.47B(+203.5%) |
| Dec 2013 | $2.11B(+17.1%) | $2.13B(+2.0%) |
| Sep 2013 | - | $2.09B(-8.6%) |
| Jun 2013 | - | $2.29B(+17.7%) |
| Mar 2013 | - | $1.94B(+4.3%) |
| Dec 2012 | $1.80B(-81.8%) | $1.86B(+9.8%) |
| Sep 2012 | - | $1.70B(-0.7%) |
| Jun 2012 | - | $1.71B(+17.6%) |
| Mar 2012 | - | $1.45B(-85.3%) |
| Dec 2011 | $9.88B(+988.7%) | $9.90B(+338.6%) |
| Sep 2011 | - | $2.26B(-0.6%) |
| Jun 2011 | - | $2.27B(-24.6%) |
| Mar 2011 | - | $3.01B(+43.5%) |
| Dec 2010 | $907.88M(-28.7%) | $2.10B(-9.1%) |
| Sep 2010 | - | $2.31B(+15.3%) |
| Jun 2010 | - | $2.00B(+21.1%) |
| Mar 2010 | - | $1.65B(-0.3%) |
| Dec 2009 | $1.27B | $1.66B(+22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $1.36B(+8.9%) |
| Jun 2009 | - | $1.24B(-39.6%) |
| Mar 2009 | - | $2.06B(+15.1%) |
| Dec 2008 | $1.46B(+50.7%) | $1.79B(-6.7%) |
| Sep 2008 | - | $1.92B(+42.4%) |
| Jun 2008 | - | $1.35B(+47.4%) |
| Mar 2008 | - | $914.20M(-22.0%) |
| Dec 2007 | $968.09M(+18.6%) | $1.17B(+52.8%) |
| Sep 2007 | - | $766.76M(-12.5%) |
| Jun 2007 | - | $876.42M(-5.3%) |
| Mar 2007 | - | $925.74M(-1.2%) |
| Dec 2006 | $816.01M(+15.3%) | $936.85M(-67.2%) |
| Sep 2006 | - | $2.85B(+91.9%) |
| Jun 2006 | - | $1.49B(-41.4%) |
| Mar 2006 | - | $2.54B(+9.3%) |
| Dec 2005 | $707.91M(+152.0%) | $2.32B(+40.0%) |
| Sep 2005 | - | $1.66B(-7.2%) |
| Jun 2005 | - | $1.79B(+21.6%) |
| Mar 2005 | - | $1.47B(+17.4%) |
| Dec 2004 | $280.91M(+44.3%) | $1.25B(+9.2%) |
| Sep 2004 | - | $1.15B(+17.7%) |
| Jun 2004 | - | $975.59M(+16.5%) |
| Mar 2004 | - | $837.64M(+18.5%) |
| Dec 2003 | $194.72M(-68.4%) | $707.00M(+13.9%) |
| Sep 2003 | - | $620.86M(-8.9%) |
| Jun 2003 | - | $681.44M(+11.3%) |
| Mar 2003 | - | $612.14M(-35.0%) |
| Dec 2002 | $616.93M(+399.6%) | $942.37M(+50.8%) |
| Sep 2002 | - | $624.79M(+11.7%) |
| Jun 2002 | - | $559.49M(-0.9%) |
| Mar 2002 | - | $564.67M(+113.9%) |
| Dec 2001 | $123.49M(-37.4%) | - |
| Dec 2000 | $197.29M(+319.7%) | - |
| Dec 1999 | $47.01M(-53.5%) | - |
| Mar 1999 | - | $263.93M(-10.8%) |
| Dec 1998 | $101.10M(+215.9%) | - |
| Sep 1998 | - | $295.86M(-5.4%) |
| Jun 1998 | - | $312.64M(-0.9%) |
| Mar 1998 | - | $315.43M(+885.7%) |
| Dec 1997 | $32.00M(-75.8%) | $32.00M(-30.0%) |
| Sep 1997 | - | $45.70M(-67.1%) |
| Jun 1997 | - | $139.00M(+32.8%) |
| Mar 1997 | - | $104.70M(-20.7%) |
| Dec 1996 | $132.00M(+381.8%) | $132.00M(-15.4%) |
| Sep 1996 | - | $156.00M(-14.7%) |
| Jun 1996 | - | $182.90M(+270.2%) |
| Mar 1996 | - | $49.40M(-31.8%) |
| Dec 1995 | $27.40M(+110.8%) | - |
| Sep 1995 | - | $72.40M(+751.8%) |
| Jun 1995 | - | $8.50M(-72.0%) |
| Mar 1995 | - | $30.40M(+98.7%) |
| Dec 1994 | - | $15.30M(-42.5%) |
| Sep 1994 | - | $26.60M(-39.1%) |
| Jun 1994 | - | $43.70M(+236.2%) |
| Mar 1994 | $13.00M(+519.0%) | $13.00M(+51.2%) |
| Dec 1993 | - | $8.60M(+309.5%) |
| Sep 1993 | - | $2.10M(-40.0%) |
| Jun 1993 | - | $3.50M(+66.7%) |
| Mar 1993 | $2.10M(-97.6%) | $2.10M(-95.6%) |
| Dec 1992 | - | $47.80M(+1978.3%) |
| Sep 1992 | - | $2.30M(-87.2%) |
| Jun 1992 | - | $17.90M(-79.6%) |
| Mar 1992 | $87.90M(+753.4%) | $87.90M(+753.4%) |
| Mar 1991 | $10.30M | $10.30M |
FAQ
- What is Gilead Sciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Gilead Sciences, Inc.?
- What is Gilead Sciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Gilead Sciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Gilead Sciences, Inc.?
- What is Gilead Sciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Gilead Sciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GILD is $9.99B
What is the all time high annual cash & cash equivalents for Gilead Sciences, Inc.?
Gilead Sciences, Inc. all-time high annual cash & cash equivalents is $17.94B
What is Gilead Sciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GILD annual cash & cash equivalents has changed by +$3.91B (+64.19%)
What is Gilead Sciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GILD is $6.52B
What is the all time high quarterly cash & cash equivalents for Gilead Sciences, Inc.?
Gilead Sciences, Inc. all-time high quarterly cash & cash equivalents is $30.95B
What is Gilead Sciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GILD quarterly cash & cash equivalents has changed by +$2.33B (+55.38%)